BL Pharmtech Corp. (KOSDAQ:065170)

BL Pharmtech Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3,622	3,864	10,607	5,024	21,752	12,380
Short-Term Investments	-	-	2,600	500	1,000	-
Cash & Short-Term Investments	3,622	3,864	13,207	5,524	22,752	12,380
Cash Growth	-28.47%	-70.74%	139.10%	-75.72%	83.78%	-55.34%
Accounts Receivable	808.67	857.1	1,011	9,208	10,364	10,230
Other Receivables	74.07	126.49	72.82	1,863	120.06	24.69
Receivables	2,906	983.6	1,083	11,071	11,097	10,592
Inventory	1,226	1,633	1,893	14,754	7,765	11,209
Prepaid Expenses	221.78	116.73	213.11	353.37	60.02	94.99
Other Current Assets	370.3	340.05	518.21	909.22	627.19	267.68
Total Current Assets	8,345	6,937	16,915	32,612	42,301	34,544
Property, Plant & Equipment	4,088	4,129	2,878	42,339	42,899	48,512
Long-Term Investments	13,523	13,884	22,056	17,011	26,439	15,671
Goodwill	-	-	-	8,000	13,151	29,389
Other Intangible Assets	154.33	221.15	548.99	1,170	1,538	1,460
Long-Term Accounts Receivable	169.86	151.09	0	-	-	0
Long-Term Deferred Tax Assets	-	-	-	1,532	1,679	1,492
Long-Term Deferred Charges	-	-	-	-	3.94	19.7
Other Long-Term Assets	10,994	11,031	2,403	1,023	2,330	2,937
Total Assets	37,378	36,458	44,802	103,687	130,341	134,325
Accounts Payable	446.18	402.83	1,078	2,845	7,254	5,490
Accrued Expenses	64.17	53.54	62.56	555.77	447.08	570.51
Short-Term Debt	3,994	1,000	-	29,092	7,817	12,552
Current Portion of Long-Term Debt	1,300	2,875	1,410	1,967	12,804	5,695
Current Portion of Leases	421.3	390.6	361.19	504.13	422.67	393.36
Other Current Liabilities	3,832	1,907	5,054	14,015	8,255	7,030
Total Current Liabilities	10,058	6,629	7,965	48,979	37,000	31,731
Long-Term Debt	-	1,300	2,343	10,739	20,694	24,854
Long-Term Leases	448.05	534.77	148.36	404	156.55	453.17
Long-Term Deferred Tax Liabilities	190.46	202.8	252.17	310.39	360	411.96
Other Long-Term Liabilities	2,939	2,914	1,787	84.29	3,852	1,581
Total Liabilities	14,301	12,190	13,002	62,604	64,832	61,408
Common Stock	13,342	4,449	44,485	44,485	44,485	43,498
Additional Paid-In Capital	93,582	102,524	101,175	99,995	100,007	92,978
Retained Earnings	-69,686	-68,625	-102,983	-95,790	-82,200	-62,070
Treasury Stock	-9.35	-1.69	-1.69	-1.69	-1.69	-1.31
Comprehensive Income & Other	-14,170	-14,099	-11,257	-14,888	-3,794	-8,304
Total Common Equity	23,058	24,247	31,419	33,800	58,497	66,102
Minority Interest	18.68	21.56	380.35	7,282	7,013	6,815
Shareholders' Equity	23,077	24,268	31,799	41,082	65,510	72,917
Total Liabilities & Equity	37,378	36,458	44,802	103,687	130,341	134,325
Total Debt	6,164	6,100	4,262	42,706	41,894	43,947
Net Cash (Debt)	-2,542	-2,236	8,945	-37,182	-19,142	-31,566
Net Cash Per Share	-95.38	-83.77	335.15	-1393.08	-726.73	-1419.45
Filing Date Shares Outstanding	26.68	2.67	26.69	26.69	26.69	26.1
Total Common Shares Outstanding	26.68	2.67	26.69	26.69	26.69	26.1
Working Capital	-1,713	308.53	8,951	-16,367	5,301	2,813
Book Value Per Share	864.29	9088.31	1177.16	1266.37	2191.67	2532.79
Tangible Book Value	22,904	24,025	30,870	24,630	43,807	35,252
Tangible Book Value Per Share	858.50	9005.41	1156.59	922.80	1641.29	1350.74
Land	-	2,538	1,812	9,553	9,553	11,285
Buildings	-	2,297	1,877	21,726	21,726	23,406
Machinery	-	402.84	396.04	16,835	15,761	15,715
Construction In Progress	-	-	-	-	32.85	135.55

Source: S&P Global Market Intelligence. Standard template. Financial Sources.